Verastem (VSTM) Announces Stock Offering

Verastem, Inc., (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares to be sold in the offering are to be sold by Verastem.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jones Ventures INTL Acquisition1 prices $200M IPO on Nasdaq
• Research Alliance Corporation IV prices $75M IPO on Nasdaq
• Crescent Biopharma launches public offering of shares and warrants